
Profiles
Mr James Conway
Weekend Duty Technician (Derriford)
School of Biological and Marine Sciences (Faculty of Science and Engineering)
Biography
Biography
I am a PhD candidate in the Kramer lab at the University of Plymouth's Derriford Research Facility. My research is focused upon the role of the E3 ubiquitin protein ligases Nedd4-1 and Nedd4-2 in the mouse dopaminergic midbrain and their crosstalk with alpha-synuclein. I am also the Alzheimer's Research UK (ARUK) early career researcher (ECR) representative for the University of Plymouth.
Prior to this I completed an MSc in Molecular Neuroscience at the University of Bristol, where my Research project was titled: "Is microRNA-7 the answer to effective GDNF treatment in Parkinson's?".
Qualifications
PhD Medical Studies - University of Plymouth - 2019-present
MSc (Distinction) Molecular Neuroscience - University of Bristol - 2018-2019
BSc (Hons) Biological Sciences - University of the West of England, Bristol - 2015-2018
Professional membership
British Neuroscience Association (BNA) - 2018-present
Teaching
Teaching
Teaching interests
I supervise both undergraduate and postgraduate, as well as placement students in the laboratory.
Research
Research
Research interests
My research is focused upon the role of the E3 ubiquitin protein ligases Nedd4-1 and Nedd4-2 in the mouse dopaminergic midbrain and their crosstalk with alpha-synuclein. In addition to this i am also interested in: Neurodegeneration, Parkinson's disease, Neurotrophic Signalling.
Grants & contracts
The influence of Nedd4 ligases on the dopaminergic midbrain and alpha synuclein in Parkinson’s Disease and Dementia with Lewy Bodies - Northcott Devon Medical Foundation (Exeter, Devon) - 2021-present - £5982
The function of E3 ubiquitin protein ligase Nedd4-1 in the brain and its crosstalk with dementia-related proteins in vivo - Alzheimer’s Research UK (Cambridge, Cambridgeshire) - 2021-present - £4988
Publications
Publications
Key publications
Key publications are highlighted
JournalsConway JA, Kramer E. Is activation of GDNF/RET signaling the answer for successful treatment of Parkinson’s disease? A discussion of data from the culture dish to the clinic Neural Regeneration Research 17(7):1462-1467 10 Dec 2021 (Journal article). DOI: 1https://doi.org/0.4103/1673-5374.327330
Conway, J.A., Ince, S., Black, S. et al. GDNF/RET signaling in dopamine neurons in vivo. Cell Tissue Res 382, 135–146 (2020). https://doi.org/10.1007/s00441-020-03268-9
Personal
Personal
Other academic activities
I am the Alzheimer's Research UK (ARUK) early career research representative for the University of Plymouth as well as the Postgraduate Research (PGR) student representative for the schools of Medicine, Dentistry and Biomedical Sciences.
Colleagues:
- Professor Edgar Kramer - Director of Studies
- Dr Michele Kiernan - Research Technician